ABBOTT LABORATORIES (ABT): SEC Filings & AI Analysis
Health Care. Latest 10-K, 10-Q, and 8-K filings for ABBOTT LABORATORIES (ABT) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.
Most recent filing — 8-K filed October 21, 2026: BEARISH Concern level: HIGH.
Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is ABBOTT LABORATORIES (ABT)?
ABBOTT LABORATORIES is a publicly traded company in the Health Care space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are ABT's most recent SEC filings?
Recent filings: 8-K (October 21, 2026), 8-K (October 21, 2026), 8-K (August 20, 2026), 10-Q (July 28, 2026), 8-K (July 16, 2026).
What does ABT's latest filing analysis show?
ABT's most recent 8-K (October 21, 2026) is rated BEARISH, concern level HIGH.
Is ABT a buy?
StockHuntr doesn't issue buy or sell ratings — it's a research tool. For ABBOTT LABORATORIES (ABT), its latest 8-K is rated HIGH concern. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.
Recent ABT filings analyzed
- 8-K · Oct 21, 2026 · concern 7.2/10
- 8-K · Oct 21, 2026 · concern 1.5/10
- 8-K · Aug 20, 2026 · concern 7.2/10
- 10-Q · Jul 28, 2026 · concern 3.2/10
- 8-K · Jul 16, 2026 · concern 1.8/10
Compare across the sector: Health Care sector analysis →
Other Health Care companies
About this analysis
- Primary source:
- View this company's filings on SEC EDGAR
- Additional data:
- Yahoo Finance (market data)
- Method:
- StockHuntr analyzes filings with AI — see our methodology.
- Analysis as of:
- October 21, 2026
- Published by:
- StockHuntr
For research and education only. Nothing here is investment advice.
Loading ABT snapshot...
Fetching live market data